PHP
EYPT icon

Parkman Healthcare Partners’s EyePoint Inc EYPT Stock Holding History

Parkman Healthcare Partners’s Portfolio EYPT Stock Details EYPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.5M Buy
1,354,800
+266,767
+25% +$3.99M 1.8% 18
2025
Q4 		$19.9M Buy
+1,088,033
New +$15.4M 1.89% 18

Other funds holding EYPT

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Parkman Healthcare Partners's EYPT Position: Q1 2026 in Review

Parkman Healthcare Partners increased its EyePoint Inc (EYPT) stake by 25% in Q1 2026, buying an estimated $3.99M and bringing the position to 1,354,800 shares worth $17.5M. The position accounts for 1.8% of the portfolio, ranked #18.

Parkman Healthcare Partners first reported a position in EYPT in Q4 2025 and has held it in 2 quarters since. The position peaked at $19.9M in Q4 2025. 188 funds tracked by Wall St. Rank hold EYPT as of Q1 2026.

  • Parkman Healthcare Partners held 1,354,800 shares of EyePoint Inc worth $17.5M as of Q1 2026.
  • Parkman Healthcare Partners bought 266,767 EyePoint Inc shares in Q1 2026, an estimated $3.99M.
  • EyePoint Inc made up 1.8% of Parkman Healthcare Partners's portfolio in Q1 2026, its #18 holding.
  • Parkman Healthcare Partners first reported a position in EyePoint Inc in Q4 2025 and has held it in 2 quarters since.
  • Parkman Healthcare Partners's EyePoint Inc position peaked at $19.9M in Q4 2025.
  • 188 funds tracked by Wall St. Rank held EyePoint Inc as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.